Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 4, 2016, Pages

  Estcourt, Lise J ^a   Stanworth, Simon J ^a   Hopewell, Sally ^b   Doree, Carolyn ^a   Trivella, Marialena ^b   Massey, Edwin ^c  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ADVERSE OUTCOME; ANTIMICROBIAL THERAPY; BONE PAIN; CLINICAL EFFECTIVENESS; CONCURRENT INFECTION; FLU LIKE SYNDROME; GRANULOCYTE TRANSFUSION; HUMAN; INFECTION; LUNG COMPLICATION; MORTALITY RATE; NEUTROPENIA; NEUTROPHIL COUNT; NEUTROPHIL DYSFUNCTION; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT RESPONSE; ADULT; CAUSE OF DEATH; CHILD; COMPLICATION; GRANULOCYTE; LEUKOCYTE TRANSFUSION; META ANALYSIS; MORTALITY; TRANSPLANTATION;

ADULT; CAUSE OF DEATH; CHILD; GRANULOCYTES; HUMANS; INFECTION; LEUKOCYTE TRANSFUSION; NEUTROPENIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84964414055     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005339.pub2     Document Type: Review

References (97)

1. Alavi JB, Roor RK, Djerassi I, Evans AE, Gluckman SJ, MacGregor RR, et al. A randomised clinical trial of granulocyte transfusions for infection in acute leukemia. New England Journal of Medicine 1977;296(13):706-11.
2. Bow EJ, Schroeder ML, Louie TJ. Pulmonary complications in patients receiving granulocyte transfusions and amphotericin B. Canadian Medical Association Journal 1984;130:593-5.
3. Herzig R, Herzig GP, Graw RG, Bull MJ, Ray KK. Successful granulocyte transfusion therapy for gram-negative septicemia. New England Journal of Medicine 1977;296(13):701-5.
4. Higby DJ, Yates JW, Henderson ES, Holland JF. Filtration leukapheresis for granulocyte transfusion therapy. New England Journal of Medicine 1975;292(15):762-6.
5. EORTC International Antimicrobial Therapy Project Group. Early granulocyte transfusions in high risk febrile neutropenic patients. Schweizerische Medizinische Wochenschrift 1983;113(Suppl. 14):46-8.
6. EORTC International Antimicrobial Therapy Project Group. Protocol for a cooperative trial of empirical antibiotic treatment and early granulocyte transfusions in febrile neutropenic patients. European Journal of Cancer 1977;13:617-21.
7. NCT00627393 . Safety and effectiveness of granulocyte transfusions in resolving infection in people With neutropenia (The RING Study). www.Clinical Trials.gov 2008 [Accessed 17th February 2015].
8. Price TH, Boeckh M, Harrison RW, McCullough J, Ness PM, Strauss RG, et al. Efficacy of transfusion with granulocytes from G-CSF/dexamethasone treated donors in neutropenic patients with infection. Blood 2015;126(18):2153-61. [DOI: 10.1182/blood-2015-05-645986]
9. Price TH, McCullough J, Ness P, Strauss RG, Pulkrabek SM, Harrison R, et al. A randomized controlled trial on the efficacy of high-dose granulocyte transfusion therapy in neutropenic patients with infection. Blood 2014;124(21):SCI-16.
10. Scali G, von Felten A, Fehr J, Sasuter Chr, Gmòr J. Granulocyte substitution in febrile leukemia patients with bone marrow aplasia. 1. Results of a prospective study [Granulozytensubstitution bei febrilen leukämiepatienten in knochenmarkaplasie]. Schweizerische Medizinische Wochenschrift 1978;108(41):1583-5.
11. Peters C, Seidel MG, Northoff H, Moog R, Boehme A, Silling G, et al. Granulocyte transfusions for treatment or prophylaxis of severe infections in immunocompromized neutropenic patients - a randomized clinical trial. ASH Annual Meeting Abstracts 2006;108(11):2934.
12. Seidel MG, Peters C, Wacker A, Northoff H, Moog R, Boehme A, et al. Randomized phase III study of granulocyte transfusions in neutropenic patients. Bone Marrow Transplantation 2008;42(10):679-84.
13. Vogler WR, Winton EF. A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. American Journal of Medicine 1977;63:548-55.
14. Winston DJ, Winston G, Gale RP. Therapeutic granulocyte transfusions for documented infections - A controlled trial in ninety-five infectious granulocytopenic episodes. Annals of Internal Medicine 1982;97:509-15.
15. Adkins D, Goodnough LT, Moellering J. Reduction in antibiotic utilization and in febrile days by transfusion of G-CSF mobilised prophylactic granulocyte components: a randomised study. Blood 1999;94:590a.
16. Altrichter J, Sauer M, Kaftan K, Birken T, Gloger D, Gloger M, et al. Extracorporeal cell therapy of septic shock patients with donor granulocytes: a pilot study. Critical Care 2011;15(2):R82.
17. Ambinder EP, Button GR, Cheung T, Goldberg JD, Holland JF. Filtration versus gravity leukapheresis in febrile granulocytopenic patients: a randomized prospective trial. Blood 1981;57:836-41.
18. Atay D, Ozturk G, Akcay A, Yanasik M, Anak S, Devecioglu O. Effect and safety of granulocyte transfusions in pediatric patients with febrile neutropenia or defective granulocyte functions. Journal of Pediatric Hematology/Oncology : Official Journal of the American Society of Pediatric Hematology/Oncology 2011;33(6):e220-5.
19. Bhatia S, McCullough J, Perry EH, Clay M, Ramsay MKC, Neglia JP. Granulocyte transfusions: efficacy in treating fungal infections in neutropenic patients following bone marrow transplantation. Transfusion 1994;34(3):226-32.
20. Blum W, Hallem C, Vij R. Improved survival in allogeneic peripheral blood stem cell transplant patients who received prophylactic granulocyte transfusions from HLA-matched donors: long term follow up. Blood 2001;98:58a.
21. Clift RA, Sanders JE, Thomas ED, Williams B, Buckner CD. Granulocyte transfusions for the prevention of infection in patients receiving bone marrow transplants. New England Journal of Medicine 1978;298:1052-7.
22. Curtis JE, Hasselback R, Bergsagel DE. Leukocyte transfusions for the prophylaxis and treatment of infections associated with granulocytopenia. Canadian Medical Association Journal 1977;117(4):341-5.
23. Curtis J E. Efficacy of granulocyte transfusions collected from non-stimulated donors. Progress in Clinical and Biological Research 1982;88:61-73.
24. Diaz, R, Soundar E, Hartman SK, Dreyer Z, Teruya J, Hui SK. Granulocyte transfusions for children with infection and neutropenia or granulocyte dysfunction. Pediatric Hematology & Oncology 2014;31(5):425-34.
25. Ford JM, Cullen MH, Roberts MM, Brown LM, Oliver RTD, Lister TA. Prophylactic granulocyte transfusions: Results of a randomised controlled trial in patients with acute myelogenous leukemia. Transfusion 1982;22:311-6.
26. Fortuny IE, Bloomfield CD, Hadlock DC, Goldman A, Kennedy BJ, McCullough JJ. Granulocyte transfusion: a controlled study in patients with acute nonlymphocytic leukemia. Transfusion 1975;15(6):548-57.
27. Freireich EJ, Lichtiger B, Mattiuzzi G, Martinez F, Reddy V, Kyle WJ. A prospective, randomized, double-blind study, comparing unirradiated to irradiated white blood cell transfusions in acute leukemia patients. Leukemia 2013;27(4):861-5.
28. NCT00968838 . A study for leukemia patients with life-threatening infections. www.clinicaltrials.gov 2008 [Accessed 17th February 2015].
29. Gomez-Villagran JL, Torres-Gomez A, Gomez-Garcia P, Martinez-Guibelalde F, Velasco-Jimena F. A controlled trial of prophylactic granulocyte transfusions during induction chemotherapy for acute nonlymphoblastic leukemia. Cancer 1984;54:734-8.
30. Grañena A, Aranalde IM, Feliu E, Muncunill J, Montserrat E, Nieto H, Rozman C. The effectiveness of granulocyte transfusions in the treatment of sever injections in granulocytopenic patients. A controlled trial (author's transl) [Eficacia de las transfusiones de granulocitos en el tratemiento de infecciones graves de pacientes granulocitopénicos]. Sangre 1978;23(3):291-7.
31. Graw RG, Herzig G, Perry S, Henderson ES. Normal granulocyte transfusion therapy - treatment of septicemia due to gram-negative bacteria. New England Journal of Medicine 1972;287(8):367-71.
32. Graw RG, Stout FG, Herzig RH, Herzig GP. Granulocyte transfusion therapy for life-threatening bacteremia: results of transfusion trials at the National Cancer Institute. Progress in Clinical and Biological Research 1977;13:267-80.
33. Hershko C, Naparstek E, Eldor A, Izak G. Granulocyte transfusion therapy - a clinical trial in patients with acute leukemia and sepsis. Vox Sanguinis 1978;34:129-35.
34. Ikemoto J, Yoshihara S, Fujioka T, Ohtsuka Y, Fujita N, Kokubunji A, et al. Impact of the mobilization regimen and the harvesting technique on the granulocyte yield in healthy donors for granulocyte transfusion therapy. Transfusion 2012;52(12):2646-52.
35. Illerhaus G, Wirth K, Dwenger A, Waller CF, Garbe A, Brass V, et al. Treatment and prophylaxis of severe infections in neutropenic patients by granulocyte transfusions. Annals of Hematology 2002;81:273-81.
36. Mannoni P, Rodet M, Vernant JP, Brun B, Coquin-Radeau EI, Bracq C, et al. Efficiency of prophylactic granulocyte transfusions in preventing infections in acute leukemia. Revue Francaise de Transfusion et Immuno-Hematologie 1979;22(5):503-18.
37. Matsue K, Harada M, Nakao S, Ueda M, Kondon K, Odaka K, et al. Controlled study of therapeutic granulocyte transfusion in granulocytopenic patients with severe infections. Japanese Journal of Clinical Oncology 1984;14(1):21-30.
38. NCT01204788 . Prophylactic white cell transfusions versus therapeutic white cell transfusions in patients with leukemia. www.Clinicaltrials.gov 2010 [Accessed 17 February 2015].
39. NCT01932710 . A feasibility study of prophylactic white blood cell transfusions. Clinical.Trials.gov 2013:[Accessed 21st April 2015].
40. Oymak Y, Ayhan Y, Karapinar TH, Devrim I, Ay Y, Sarihan H, et al. Granulocyte transfusion experience in pediatric neutropenic fever: Splitted product can be an alternative?. Transfusion & Apheresis Science 2015;53(3):348-52.
41. Oza A, Hallemeier C, Goodnough L, Khoury H, Shenoy S, Devine S, et al. Granulocyte-colony-stimulating factor-mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage. Transfusion 2006;46(1):14-23. [MEDLINE: 16398726]
42. Pammi M, Brocklehurst P. Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropenia. Cochrane Database of Systematic Reviews 2011, Issue 10. [DOI: 10.1002/14651858.CD003956.pub2]
43. Schiffer CA, Aisner J, Daly PA, Schimpff SC, Wiernick PH. Alloimmunisation following prophylactic granulocyte transfusion. Blood 1979;54:766-74.
44. Stout IP, Reeves HM, Maitta RW. Analysis of the effectiveness of granulocyte transfusions in neutropenic patients at a large tertiary academic medical center. Transfusion 2015;55:164A.
45. NCT00000581 . Granulocyte Transfusion Study. Clinical.Trials.gov 1999:[Accessed 21st April 2015].
46. Strauss RG, Connett JE, Gale RP, Bloomfield CD, Herzig GP, McCullough J, et al. A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. New England Journal of Medicine 1981;305:597-603.
47. Strauss RG. Neutrophil/granulocyte transfusions collected from G-CSF + dexamethasone-stimulated donors. Current Opinion in Hematology 2015;22(6):565-7.
48. Sutton DMC, Shumak KH, Baker MA. Prophylactic granulocyte transfusions in acute leukemia. Plasma Therapy and Transfusion Technology 1982;3:45-50.
49. UMIN000014777 . Study on safety and efficacy of granulocyte transfusion mobilized with G-CSF in related donor. UMIN Clinical Trials Registry 2014:[Accessed 24th April 2015].
50. Winston DJ, Ho WG, Young LS, Gale RP. Prophylactic granulocyte transfusions during human bone marrow transplantation. American Journal of Medicine 1982;68:893-7.
51. Witt V, Pichler H. Survey of patients receiving Leukocyte transfusions from 2012 until 2014, a one center retrospective analysis. Transfusion Medicine and Hemotherapy 2015;48(42):9.
52. Yoshihara S, Ikemoto J, Fujimori Y. Update on granulocyte transfusions: accumulation of promising data, but still lack of decisive evidence. Current Opinion in Hematology 2016;23(1):55-60.
53. Transfusion of granulocytes for patients with febrile neutropenia. German Clinical Trials Register (DRKS) 2011 (Date Accessed 21 April 2015).
54. Bashir S, Cardigan R. Granulocyte concentrates: how can we assess their quality?. Transfusion Medicine 2003;13:245.
55. Bashir S, Stanworth S, Massey E, Goddard F, Cardigan R. Neutrophil function is preserved in a pooled granulocyte component prepared from whole blood donations. British Journal of Haematology 2008;140:701-11.
56. Bennett CL, Evens AM, Andritsos LA. Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. British Journal of Haematology 2006;135(5):642-50.
57. Brecher G, Wilbur KM, Cronkite EP. Transfusions of separated leukocytes into irradiated dogs with aplastic marrows. Proceedings of the Society for Experimental Biology and Medicine 1953;84:54-6.
58. Bux J, Cassens U, Dielschnider T, Duchscherer M, Edel E, Eichler H, et al. Tolerance of granulocyte donors toward granulocyte colony-stimulating factor stimulation and of patients towards granulocyte transfusions: results of a multicentre study. Vox Sanguinis 2003;85:322-5.
59. Dale DC, Reynolds HY, Pennington JE, Elin RJ, Herzig GP. Experimental Pseudomonas pneumonia in leukopenic dogs: comparison of therapy with antibiotics and granulocyte transfusions. Blood 1976;47:869-76.
60. Dale DC, Liles WC. Return of granulocyte transfusions. Current Opinion in Pediatrics 2000;12:18-22.
61. de la Rubia J, de Arriba F, Arbona C, Pascual MJ, Zamora C, Insunza A, et al. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry. Haematologica 2008;93(5):735-40.
62. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
63. Dellinger R, Levy M, Rhodes A, Annane D, Gerlach H, Opal S, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Medicine 2013;39:165-228.
64. Engelfriet CO, Reesink HW. Granulocyte transfusions. Vox Sanguinis 2000;79:59-96.
65. Estcourt LJ, Stanworth S, Doree C, Blanco P, Hopewell S, Trivella M, et al. Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunction. Cochrane Database of Systematic Reviews 2015, Issue 6. [DOI: 10.1002/14651858.CD005341.pub3]
66. Freireich EJ, Levin RH, Whang J, Carbone PP, Bronson W, Morse EE. The function and fate of transfused leukocytes from donors with chronic myelocytic leukemia in leukopenic recipients. Annals of the New York Academy of Sciences 1964;113:1081-90.
67. Ghodsi Z, Strauss RG. Cataracts in neutrophil donors stimulated with adrenal corticosteroids. Transfusion 2001;41:1464-8.
68. Goldman JM, Madrigal JA, Pamphilon D. Possible harmful effects of short course granulocyte colony-stimulating factor in normal donors. British Journal of Haematology 2006 December;8:155-60.
69. Gutierrez-Delgado F, Bensigner W. Safety of granulocyte colony-stimulating factor in normal donors. Current Opinion in Haematology 2001;8:155-60.
70. Higgins JPT, Deeks JJ (editors). Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
71. Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
72. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
73. Hubel K, Dale DC, Engert A, Liles WC. Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases. Journal of Infectious Diseases 2001;183:321-8.
74. Hubel K, Carter R, Liles WC, dale DC, Price TH, Bowden RA, et al. Granulocyte transfusion therapy for infections in candidates and recipients of hematopoietic stem cell transplant: a comparative analysis of feasibility and outcome of community donors versus related donors. Transfusion 2002;42:1414-21.
75. Hölig K. G-CSF in healthy allogeneic stem cell donors. Transfusion Medicine and Hemotherapy 2013;40(4):225-35.
76. Kadri SS, Remy KE, Strich JR, Gea-Banacloche J, Leitman, SF . Role of granulocyte transfusions in invasive fusariosis: systematic review and single-center experience. Transfusion 2015; Vol. On-line ahead of print.
77. Klastersky J. Empirical treatment of sepsis in neutropenic patients. Hospital Medicine (London) 2001;62(2):101-3.
78. Kuijpers TW, Weening RS, Roos D. Clinical and laboratory work-up of patients with neutrophil shortage or dysfunction. Journal of Immunological Methods. 1999;232:211-29.
79. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
80. Legrand M, Max A, Peigne V, Mariotte E, Canet E, Debrumetz A, et al. Survival in neutropenic patients with severe sepsis or septic shock. Critical Care Medicine 2012;40(1):43-9.
81. Massey E, Harding K, Kahan BC, Llewelyn C, Wynn R, Moppett J, et al. The granulocytes in neutropenia 1 (GIN 1) study: a safety study of granulocytes collected from whole blood and stored in additive solution and plasma. Transfusion Medicine 2012;22(4):277-84.
82. National Institute for Health and Clinical Excellence (NICE). Neutropenic sepsis: prevention and management of neutropenic sepsis in cancer patients. NICE Guidelines 2012; Vol. CG151.
83. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
84. The Nordic Cochrane Centre. Review Manager (RevMan). Version Version 5.3. Copenhagen: The Cochrane Collaboration, 2014.
85. Robinson SP, Marks DI. Granulocyte transfusions in the G-CSF era. Where do we stand?. Bone Marrow Transplantation 2004;34(10):839-46.
86. Sacco JJ, Botten J, Macbeth F, Bagust A, Clark P. The average body surface area of adult cancer patients in the UK: a multicentre retrospective study. PLoS One 2010;5(1):e8933. [DOI: 10.1371/journal.pone.0008933]
87. Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
88. Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
89. Stovold E, Beecher D, Foxlee R, Noel-Storr A. Study flow diagrams in Cochrane systematic review updates: an adapted PRISMA flow diagram. Systematic Reviews 2014;3(1):54.
90. Strauss RG. Clinical perspectives of granulocyte transfusions: efficacy to date. Journal of Clinical Apheresis 1995;10:114-8.
91. Strauss RG. Granulocyte (neutrophil) transfusion. Apheresis: Principles and Practice. Bethesda: AABB Press, 2003:237-52.
92. Strumia MM. The effect of leukocytic cream injections in the treatment of the neutropenias. American Journal of Medicine 1934;187:527-44.
93. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007; Vol. 8, issue 16. [DOI: 10.1186/1745-6215-8-16]
94. Vamvakas EC, Pineda AA. Meta-analysis of clinical studies of the efficacy of granulocyte transfusions in the treatment of bacterial sepsis. Journal of Clinical Apheresis 1996;11(1):1-9.
95. Vamvakas EC, Pineda AA. Determinants of the efficacy of prophylactic granulocyte transfusions: a meta-analysis. Journal of Clinical Apheresis 1997;12(2):74-81.
96. World Health Organization. International statistical classification of diseases and related health problems. 10th Edition. Vol. 1, Geneva: World Health Organization, 1992.
97. Stanworth S, Massey E, Hyde C, Brunskill SJ, Navarette C, Lucas G, et al. Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction. Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/14651858.CD005339]